Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
25
References
1
Citations
NaN
KQI